Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-30 @ 2:01 AM
Study NCT ID:
NCT06699459
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-21
First Post:
2024-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
Sponsor:
Sir Run Run Shaw Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SRRSH.20240559
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None